Advertisement
week in cancer news
  • July 12: The Week in Cancer News

    A combination of three targeted therapies can lengthen survival for some patients with metastatic colorectal cancer, and patients receiving stem cell transplants can benefit from shingles vaccines.

    by Kate Yandell

  • Starting a Conversation

    Palliative care physician Dawn Gross helps people talk about death by focusing on what they want during life.

    by Amy Paturel

  • Helping Cancer Survivors Sleep

    A clinical trial comparing acupuncture and cognitive behavioral therapy found that they are both helpful for people who are experiencing sleep problems after cancer treatment.

    by Cheryl Platzman Weinstock

  • June 28: The Week in Cancer News

    A study indicates that many African Americans who could benefit from lung cancer screening are not eligible, and an oncologist writes about his experiences with medical aid in dying.

    by Kate Yandell

  • Cancer Care on a Native American Reservation

    For the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.

    by Kate Yandell

  • Walking Back From Cancer

    An American expat in Norway describes how a favorite walking trail aided him during treatment and recovery.

    by Steven Ford

  • Proton Therapy Is Associated With Reduced Side Effects

    When combined with chemotherapy, the newer form of radiation comes with fewer severe side effects than standard radiation therapy, a study suggests.

    by Sue Rochman

  • June 21: The Week in Cancer News

    A study shows that more than a third of U.S. cancer survivors experience chronic pain, and the U.S. Food and Drug Administration approves another immunotherapy for treatment of small cell lung cancer.

    by Kate Yandell

  • June 14: The Week in Cancer News

    A physician writes about the long-term effects of her treatment for Hodgkin lymphoma in the 1960s, and the U.S. Food and Drug Administration approves an immunotherapy drug as an initial treatment for metastatic head and neck cancer.

    by Kate Yandell

  • So You Want to Serve on a Scientific Review Panel?

    Cancer patient advocates who review research proposals can provide valuable perspective.

    by Bob Riter, Monica Vakiner and Carole Baas